Charles River is a leading early-stage contract research organization who provides essential products and services to pharmaceutical and biotechnology companies, government agencies, and leading academic institutions to help accelerate their research and drug development efforts. HemaCare and Charles River have formed a partnership to advance human immune system research by developing a more efficient and reliable method of working with humanized mice. Under this partnership, vials of pre-selected peripheral blood mononuclear cells (PBMCs) from HemaCare will be integrated into Charles River’s NCG/PBMC Select Humanization Kit, allowing the researcher to efficiently develop the humanized mouse model.
Miltenyi Biotec is a global provider of products and services that advance biomedical research and cellular therapy. The company’s integrated tools support research at every level, from basic research to translational research to clinical application. Their technologies cover techniques of sample preparation, cell isolation, flow sorting, flow cytometry, cell culture, molecular analysis, and preclinical imaging. The company’s more than 25 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer, and clinical research areas like hematology, graft engineering, and apheresis. Trusted around the world, the Miltenyi Biotec brand continues to set new standards in the industry.
Success in the regenerative medicine, biobanking, and drug discovery industries depends on the shelf life and viability of cells, tissues, and organs designated for research or clinical applications. Hand in hand with many of these applications is the need for high quality biologically functional cells. BioLife Solutions and HemaCare have partnered together to help you be successful with controlled, consistently functional cells and best-in-class, cGMP-grade biopreservation media products that significantly extend stability and improve post-biopreservation viability and function of your biologic source material, intermediates, and final products.
The Cryoport Solution replaces dry ice, virtually eliminating the risk of cell degradation during frozen transportation. Cryoport uses custom-built liquid nitrogen dry vapor shippers to maintain stable temperatures. Cryoport is the expert in deep-frozen shipping for biological materials with the most advanced Logistics Management Platform in the industry.
Brooks Automation is the global leader in automated cold chain sample logistics management for drug discovery and biostorage applications. Brooks Automation products enable researchers, clinicians, and manufacturers to protect temperature-sensitive therapeutics, biological samples, and biomaterials thus improving the success of therapeutic discovery and enabling effective care delivery.